Open AccessRenin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer
Author(s) -
Michael L. Blute,
Timothy J. Rushmer,
Fangfang Shi,
Benjamin Fuller,
E. Jason Abel,
David F. Jarrard,
Tracy M. Downs
Publication year - 2015
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2015.05.104
Subject(s) - medicine , bladder cancer , urology , renin–angiotensin system , tumor progression , resection , cancer , surgery , blood pressure
Prior reports suggest that renin-angiotensin system inhibition may decrease nonmuscle invasive bladder cancer recurrence. We evaluated whether angiotensin converting enzyme inhibitor or angiotensin receptor blocker treatment at initial surgery was associated with decreased recurrence or progression in patients with nonmuscle invasive bladder cancer.